Pharmaceutical composition and the process for its preparation

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S256000, C514S258100, C514S365000, C514S369000

Reexamination Certificate

active

07439248

ABSTRACT:
The present invention provides a new stable pharmaceutical composition containing 5-[[4-[3-Methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenyl-methyl]thiadiazolidine-2,4-dione as active ingredient.

REFERENCES:
patent: 4280997 (1981-07-01), Van Leverink
patent: 5532256 (1996-07-01), Malamas et al.
patent: 5972970 (1999-10-01), Sohda et al.
patent: 6710050 (2004-03-01), Weibel et al.
patent: 6866867 (2005-03-01), Staniforth et al.
patent: 0 945 134 (1999-09-01), None
patent: WO 92/17161 (1992-10-01), None
patent: WO 95/06461 (1995-03-01), None
patent: WO 96/18386 (1996-06-01), None
patent: WO 97/41097 (1997-11-01), None
patent: WO 98/45291 (1998-10-01), None
patent: WO 2006002255 (2005-06-01), None
patent: WO 2006002255 (2005-06-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition and the process for its preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition and the process for its preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition and the process for its preparation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4008975

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.